| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Alessandro Serretti, Laura Mandelli, Cristina Lorenzi, Adele Pirovano, Paolo Olgiati, Cristina Colombo, Enrico Smerald. Serotonin transporter gene influences the time course of improvement of "core" depressive and somatic anxiety symptoms during treatment with SSRIs for recurrent mood disorders. Psychiatry research. vol 149. issue 1-3. 2007-04-10. PMID:17157919. |
serotonin transporter gene influences the time course of improvement of "core" depressive and somatic anxiety symptoms during treatment with ssris for recurrent mood disorders. |
2007-04-10 |
2023-08-12 |
Not clear |
| Xiaohua Li, Kelley M Rosborough, Ari B Friedman, Wawa Zhu, Kevin A Rot. Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics. The international journal of neuropsychopharmacology. vol 10. issue 1. 2007-03-30. PMID:16672106. |
we previously reported that serotonin, a major neurotransmitter involved in mood disorders, regulates gsk3 by acutely increasing its n-terminal serine phosphorylation. |
2007-03-30 |
2023-08-12 |
mouse |
| Vikas Kaura, Colin D Ingram, Sarah E Gartside, Allan H Young, Sarah J Judg. The progesterone metabolite allopregnanolone potentiates GABA(A) receptor-mediated inhibition of 5-HT neuronal activity. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 17. issue 2. 2007-03-02. PMID:16574382. |
this effect on 5-ht neurotransmission may have relevance for mood disorders commonly associated with reproductive hormone events, such as premenstrual dysphoric disorder and postpartum depression. |
2007-03-02 |
2023-08-12 |
Not clear |
| P Paruchuri, D Godkar, D Anandacoomarswamy, K Sheth, S Niranja. Rare case of serotonin syndrome with therapeutic doses of paroxetine. American journal of therapeutics. vol 13. issue 6. 2007-02-09. PMID:17122538. |
paroxetine (paxil) is a selective serotonin reuptake inhibitor (ssri) and anxiolytic that is approved to treat numerous mood disorders. |
2007-02-09 |
2023-08-12 |
Not clear |
| Graziano Pinna, Erminio Costa, Alessandro Guidott. Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Psychopharmacology. vol 186. issue 3. 2006-12-04. PMID:16432684. |
based on these findings, it could be inferred that the increase of brain allo content elicited by fluoxetine and norfluoxetine, rather than the inhibition selective of 5-ht reuptake, may be operative in the fluoxetine-induced remission of the behavioral abnormalities associated with mood disorders. |
2006-12-04 |
2023-08-12 |
mouse |
| Carmen Mannucci, Michele Tedesco, Maria Bellomo, Achille P Caputi, Gioacchino Calapa. Long-term effects of nicotine on the forced swimming test in mice: an experimental model for the study of depression caused by smoke. Neurochemistry international. vol 49. issue 5. 2006-10-18. PMID:16697079. |
our results show that (i) behavioural alterations estimated with forced swimming test and (ii) changes in diencephalic serotonin content and 5-ht(1a) receptor expression, are present since nicotine is withdrawn even after a long time, suggesting a role of serotonin in mood disorders eventually occurring following smoking cessation. |
2006-10-18 |
2023-08-12 |
mouse |
| Howard O'Rourke, Julie L Fudg. Distribution of serotonin transporter labeled fibers in amygdaloid subregions: implications for mood disorders. Biological psychiatry. vol 60. issue 5. 2006-10-12. PMID:16414028. |
distribution of serotonin transporter labeled fibers in amygdaloid subregions: implications for mood disorders. |
2006-10-12 |
2023-08-12 |
Not clear |
| Howard O'Rourke, Julie L Fudg. Distribution of serotonin transporter labeled fibers in amygdaloid subregions: implications for mood disorders. Biological psychiatry. vol 60. issue 5. 2006-10-12. PMID:16414028. |
the serotonin transporter 5-htt mediates responses to serotonin reuptake inhibitors (ssris), a mainstay treatment in mood disorders. |
2006-10-12 |
2023-08-12 |
Not clear |
| Sven Ove Ogren, Eugenia Kuteeva, Tomas Hökfelt, Jan Keh. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders. CNS drugs. vol 20. issue 8. 2006-09-19. PMID:16863269. |
in fact, current pharmacological treatment for mood disorders is based on the use of drugs that act mainly by enhancing brain serotonin and noradrenaline neurotransmission by blockade of the active reuptake mechanism for these neurotransmitters. |
2006-09-19 |
2023-08-12 |
mouse |
| Sven Ove Ogren, Eugenia Kuteeva, Tomas Hökfelt, Jan Keh. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders. CNS drugs. vol 20. issue 8. 2006-09-19. PMID:16863269. |
these results indicate an important (mainly inhibitory) role of galanin as a regulator of brain serotonin and 5-ht1a receptor-mediated transmission, which may be of potential importance for understanding mood disorders and for the development of antidepressant drugs. |
2006-09-19 |
2023-08-12 |
mouse |
| Leandro Michelon, Ivanor Meira-Lima, Quirino Cordeiro, Karen Miguita, Gerome Breen, David Collier, Homero Vallad. Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder. Neuroscience letters. vol 403. issue 3. 2006-09-01. PMID:16787706. |
in the present study we investigated the influence of a series variants in genes (the serotonin transporter, glycogen synthase kinase-3beta, inositol polyphosphatase 1-phosphate, brain-derived neurotrophic factor and activator protein 2beta) related to the action of lithium carbonate, a drug used for prophylaxis in mood disorders. |
2006-09-01 |
2023-08-12 |
Not clear |
| Nicole Helbecque, D Larry Sparks, John C Hunsaker, Philippe Amouye. The serotonin transporter promoter polymorphism and suicide. Neuroscience letters. vol 400. issue 1-2. 2006-08-04. PMID:16510244. |
a functional polymorphism (a 44-base pair insertion (l)/deletion (s)) in the promoter of the gene encoding the serotonin transporter (5-httlpr), associated with mood disorders, has been inconsistently associated with suicidality. |
2006-08-04 |
2023-08-12 |
human |
| Ting-Hsiu Chen, Tsuo-Hung Lan, Chin-Yi Yang, Kai-Dih Juan. Postpartum mood disorders may be related to a decreased insulin level after delivery. Medical hypotheses. vol 66. issue 4. 2006-06-14. PMID:16321476. |
while serotonergic nervous system is well known for its important role in the development of mood disorders, decreased insulin level may induce mood disorders through the mechanism of affecting serotonin secretion in the brain. |
2006-06-14 |
2023-08-12 |
Not clear |
| Chloé Alexandre, Daniela Popa, Véronique Fabre, Saoussen Bouali, Patrice Venault, Klaus-Peter Lesch, Michel Hamon, Joëlle Adrie. Early life blockade of 5-hydroxytryptamine 1A receptors normalizes sleep and depression-like behavior in adult knock-out mice lacking the serotonin transporter. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 26. issue 20. 2006-06-08. PMID:16707806. |
the reversal of sleep alterations and depression-like behavior after early life blockade of 5-ht(1a)r in 5-htt-/- mutants might open new perspectives regarding preventive care of sleep and mood disorders resulting from serotonin transporter impairments during development. |
2006-06-08 |
2023-08-12 |
mouse |
| Cristina Lorenzi, Alessandro Serretti, Laura Mandelli, Viviana Tubazio, Cristina Ploia, Enrico Smerald. 5-HT 1A polymorphism and self-transcendence in mood disorders. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 137B. issue 1. 2006-05-30. PMID:15952185. |
5-ht 1a polymorphism and self-transcendence in mood disorders. |
2006-05-30 |
2023-08-12 |
human |
| Cristina Lorenzi, Alessandro Serretti, Laura Mandelli, Viviana Tubazio, Cristina Ploia, Enrico Smerald. 5-HT 1A polymorphism and self-transcendence in mood disorders. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics. vol 137B. issue 1. 2006-05-30. PMID:15952185. |
we tested involvement of 5-ht(1a) gene in this trait, in a sample of 40 remitted mood disorder patients. |
2006-05-30 |
2023-08-12 |
human |
| R Iceta, J E Mesonero, J J Aramayona, A I Alcald. Molecular characterization and intracellular regulation of the human serotonin transporter in Caco-2 cells. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society. vol 57. issue 1. 2006-05-22. PMID:16601320. |
the serotonin transporter (sert) has shown itself to be an effective pharmacological target in the treatment of mood disorders and some kinds of gastrointestinal syndromes. |
2006-05-22 |
2023-08-12 |
human |
| Seena Fazel, Martin Grann, Guy M Goodwi. Suicide trends in discharged patients with mood disorders: associations with selective serotonin uptake inhibitors and comorbid substance misuse. International clinical psychopharmacology. vol 21. issue 2. 2006-03-28. PMID:16421463. |
suicide trends in discharged patients with mood disorders: associations with selective serotonin uptake inhibitors and comorbid substance misuse. |
2006-03-28 |
2023-08-12 |
Not clear |
| Seena Fazel, Martin Grann, Guy M Goodwi. Suicide trends in discharged patients with mood disorders: associations with selective serotonin uptake inhibitors and comorbid substance misuse. International clinical psychopharmacology. vol 21. issue 2. 2006-03-28. PMID:16421463. |
we determined the rates of suicide in two consecutive time intervals of low and high selective serotonin reuptake inhibitor (ssri) prescribing for men and women with mood disorders, who were at relatively high risk of suicide, in a discharged hospitalized sample. |
2006-03-28 |
2023-08-12 |
Not clear |
| Cathy W Levenso. Zinc: the new antidepressant? Nutrition reviews. vol 64. issue 1. 2006-03-28. PMID:16491668. |
with the hope of understanding the role of zinc in mood disorders, recent work has begun to explore possible mechanisms of zinc action on serotonin uptake in the brain. |
2006-03-28 |
2023-08-12 |
Not clear |